Other psychoactive substance dependence with withdrawal delirium
ICD-10 F19.231 is a billable code used to indicate a diagnosis of other psychoactive substance dependence with withdrawal delirium.
F19.231 refers to a diagnosis of dependence on other psychoactive substances, characterized by the presence of withdrawal delirium. This condition arises when an individual has developed a physical and psychological dependence on substances not classified under the more common categories such as alcohol, opioids, or stimulants. Withdrawal delirium is a severe form of withdrawal syndrome that can manifest as confusion, agitation, hallucinations, and autonomic instability. Patients may experience significant distress and impairment in social, occupational, or other important areas of functioning. The diagnosis requires careful assessment of the patient's substance use history, clinical presentation, and the timing of withdrawal symptoms in relation to substance cessation. Treatment typically involves a combination of pharmacological interventions to manage withdrawal symptoms and psychological support to address the underlying substance use disorder. Comprehensive treatment programs may include inpatient detoxification, outpatient therapy, and support groups to promote recovery and prevent relapse.
Detailed history of substance use, withdrawal symptoms, and treatment plan.
Patients presenting with acute withdrawal symptoms, requiring detoxification.
Ensure comprehensive assessment of all substances used and their impact on the patient's health.
Mental status examination, assessment of co-occurring disorders, and treatment response.
Patients with dual diagnoses of substance use disorder and mental health conditions.
Documenting the interplay between substance use and psychiatric symptoms is crucial.
Used when assessing a patient for substance dependence and withdrawal symptoms.
Document the assessment findings and treatment recommendations.
Addiction specialists should ensure comprehensive evaluations are performed.
Key symptoms include confusion, agitation, hallucinations, and autonomic instability, which can be life-threatening if not managed properly.
